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ABSTRACT 
Objective: The aim of the present work was to prepare solid dispersion of ibuprofen with PEG 6000 to increase the aqueous solubility of the drug 
and to develop the solid dispersed ibuprofen into tablet formulation with the combination of a hydrophilic and hydrophobic polymer to attain 
controlled release of ibuprofen. 
Methods: Solid dispersion of ibuprofen was prepared by melting-solvent method by varying the ratio of drug and PEG 6000. The solid dispersed 
ibuprofen was subjected to tablet formulation by using a hydrophilic swellable polymer-carbopol and hydrophobic non-swellable polymer-ethyl 
cellulose. The release of the drug from the polymer matrix was studied as the polymer ratio changes. 
Results: Compatibility between drug and polymers was established from FT-IR study. The saturated solubility was found to increase in the solid 
dispersed formulation. The swelling index was found within the range of 90±5.43 to 137±6.41. SEM image of swollen tablet confirmed the presence 
of irregular and porous surface. The cumulative drug release was found to vary within the range of 68.76±3.04 to 95.33±2.34 % after 8 h of 
dissolution.  
Conclusion: The combination of solid dispersion and application of hydrophilic and hydrophobic polymers in matrix formation can facilitate better 
dissolution and absorption profile with greater patient compliance. 
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Orally administered drugs go through dissolution and then permeate 
across the epithelial membrane before appearing in the systemic 
circulation. Apart from solubility and permeability, the dissolution 
rate of the drug is one of the major factors for the bioavailability of 
the drug. Solubility of the drug in the gastro-intestinal medium is a 
major concern for most of the drugs [1]. Around 40 % of the new 
drug substances are having poor aqueous solubility. This leads to 
reduced bioavailability and possible adverse effects [2]. Thus 
solubility of new drug substances is the biggest challenge to 
formulation scientists [3, 4]. In spite of these challenges, oral route 
has been predominantly preferred route for drug administration due 
to its easy administration, high patient compliance and flexibility in 
dosage form design [3, 5].  
Ibuprofen, a non-steroidal anti-inflammatory drug (NSAID) widely 
used to reduce pain, tenderness, inflammation, and stiffness caused by 
gout and arthritis [6]. It is also used in the therapy of muscle ache, 
fever, menstrual pain and post-surgical pain [7]. Ibuprofen is a non-
selective inhibitor of cyclooxygenase (COX) which inhibits two isoform 
of cyclooxygenase, COX-1, and COX-2 [8]. The inhibition of COX-1 is 
responsible for unwanted effects on GI tract and platelet aggregation, 
whereas COX-2 is responsible for the analgesic, antipyretic, and anti-
inflammatory activity of NSAIDs [9, 10]. However, the function of each 
isoform of COX on analgesic, antipyretic, anti-inflammatory activity, 
and the severity of gastric damage of NSAIDs is uncertain and different 
compounds can cause different degrees of physiological effects and 
gastric damage [11, 12]. 
Solid dispersions can be defined as a dispersion of one or more 
active ingredients in an inert carrier or matrix in the solid state 
prepared by co-melting or solvent extraction or by the solvent-
melt method [13]. Solid dispersion drug formulation represents an 
excellent method to enhance the solubility of poorly water-soluble 
drugs, as well as for the reduction of the ulcerogenic effect of non-
steroidal anti-inflammatory drugs (NSAIDs). Ibuprofen is a BCS 
class II drug with less solubility and high permeability [14]. Use of 
solid dispersion technique can enhance the solubility and 
dissolution rate and result in increasing the drug absorption of 
several BCS class II drugs [15-17]. The promising outcome of solid 
dispersion in enhancement of solubility and dissolution rate of 
poorly soluble drugs can be attributed to different aspects, such as 
crystalline to amorphous structure, improvement of local 
solubility and wettability for poorly soluble drugs in solid 
dispersion matrix and formation of metastable form of drug with 
increased solubility and dissolution rate in the presence of carrier 
[18, 19]. In present work, an attempt has been made to develop 
controlled release matrix tablets of solid dispersed ibuprofen. A 
combination of swellable hydrophilic polymer and the non-
swellable hydrophobic polymer was used to control the drug 
release from tablet matrix. 
MATERIALS AND METHODS 
Materials 
Ibuprofen was received as a gift sample from Aurobindo Pharma 
Ltd., Hyderabad, India. Carbopol 934, Magnesium stearate and talc 
were commercially procured from Loba Chemie Pvt. Ltd., India. PEG 
6000 was procured from Merck. Ethyl cellulose and lactose were 
purchased from SD Fine Chemicals. All the chemicals used were of 
analytical grade. 
Methods 
Fourier transform infrared spectroscopy 
Drug-excipient interaction plays a vital role in the stability of drug 
from the formulation. Fourier transmitted infrared (FTIR) 
spectroscopy has been used to study the physical and chemical 
interactions between drugs and excipients. FT-IR spectra were 
recorded with FT-IR spectrometer (IRAffinity-1S, Shimadzu, Japan). 
Each sample was powdered and mixed with KBr (Uvasol, Merck, and 
KgaA, Germany). Pellets were prepared by using hydraulic press 
with a pressure of 100 Kg/cm2 for 15 min. The pellets were then 
scanned from 4000 to 400 cm-1 with a mirror speed of 2 mm/sec. 
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Drug-excipient compatibility study was carried out by the FT-IR 
analysis of pure drug ibuprofen, and the formulation containing 
ibuprofen and polymers [20]. 
Preparation of solid dispersion of ibuprofen 
Solid dispersion of ibuprofen was prepared by melting-solvent 
method. Accurately weighed quantity of drug was taken in a clean 
and dry glass mortar and triturate well to a fine powder. Add 
sufficient quantity of methanol to above powder and triturate to 
get a uniform dispersion. Required amount of PEG 6000 was taken 
in a glass container and melted in a water bath at 60̊ C [21 , 22]. 
Then the ibuprofen-methanol solution was added to the molten 
mass of PEG 6000 and mixed uniformly for 5 min. Then the 
mixture was placed on ice bath for rapid cooling until it solidified. 
The hardened mass was powdered in a mortar and then sieved 
through sieve no 60. Then it was stored in an airtight glass vial at 
room temperature [23, 24]. 
Preparation of controlled release matrix tablets of solid 
dispersed ibuprofen 
Six different formulations of ibuprofen were prepared by varying the 
polymer concentrations. All the ingredients, in which the drug, 
carbopol, ethyl cellulose, anhydrous lactose, talc, and magnesium 
stearate were weighed individually and sifted manually through 
mesh # 40 separately. Thereafter, drug, ethyl cellulose, carbopoland 
lactose were mixed uniformly. Talc and magnesium stearate were 
finally added as lubricant and then mixed for further 5 min. The 
weight of the tablet was determined as 500 mg and the tablets were 
compressed (Rimek press) using a punch and die set to produce 
round shaped tablets with 3.35 mm thickness dimensions. 
Formulations F2 to F6 were also prepared by direct compression 
method but instead of pure ibuprofen, an equivalent weight of solid 
dispersed ibuprofen was used. Combinations of hydrophobic and 
hydrophilic polymers were used in a different concentration in 
order to achieve a controlled release of ibuprofen [25]. 
 
Table 1: Formulation of ibuprofen solid dispersed matrix tablets 
Ingredients (mg) F1 F2 F3 F4 F5 F6 
Ibuprofen or solid dispersed ibuprofen equivalent to 100 100 100 100 100 100 
PEG 6000 - 100 150 200 250 300 
Carbopol 15 20 25 30 35 40 
Ethyl Cellulose 35 30 25 20 15 10 
Lactose 330 230 180 130 80 30 
Talc 10 10 10 10 10 10 
Magnesium Stearate 10 10 10 10 10 10 
 
Evaluation of pre-compression parameters for powder blend 
All the pre-compression parameters such as bulk density, tapped 
density, angle of repose, Carr’s index, Hausner’s ratio were 
measured by following standard procedure [26].  
Evaluation of post-compression parameters of ibuprofen solid 
dispersed tablets 
Tablet thickness 
Five tablets from each formulation were selected randomly and used for 
thickness test. Thickness of the prepared solid dispersed tablets was 
measured in mm by using Vernier calliper (Acculab, Ambala, India) [27].  
Hardness test 
Randomly selected five tablets were taken for hardness test which 
was subjected to “Monsanto” hardness tester by fitting them 
between the spindle and anvil through their diameter. The pressure 
was gradually increased then by turning the knurled knob until the 
tablet breaks. The force (Kg) required to break the tablet is noted 
from the scale [27]. 
Friability test 
The friability of tablets was determined by “Roche” friabilator. 10 
tablets were weighted and placed in a plastic chamber of friabilator 
and allowed to rotate 100 revolutions at 25 rpm for 4 min. Then the 
tablets were removed, de-dusted and reweighed. The percentage 
friability was calculated as per formula [28]. 
 
Weight variation test 
Average weights of randomly selected twenty tablets were 
determined by weighing them individually. Individual weights of the 
tablets were compared with the average weight. If more than two of 
the individual weights should deviate from the average weight by 
more than 7.5 % deviation and none should deviate by more than 
twice the percentage [27]. 
Determination of saturated solubility 
Amodified solubilitydetermination method was used to determine the 
solubility of pure ibuprofen and solid dispersed ibuprofen. Solubility 
study for all the samples along with pure ibuprofen was carried out in 
distilled water. Pure ibuprofen and solid dispersed ibuprofen were taken 
in excess quantity in a stopper conical flask containing 10 ml of distilled 
water. Then the flasks were sealed and shaken on a rotary shaker for 24 
h. The sample solutions were collected and then filtered through 
Whatmann filter paper. Then 1 ml of filtered solution was taken and 
suitably diluted with the respective media before measuring the 
absorbances in UV-Visible spectrophotometer at 220 nm. The solubility 
of all the samples was determined in triplicates and the mean value and 
standard deviation were noted [29]. 
Drug content uniformity 
10 tablets were selected randomly and then weighed and powdered 
by using a glass mortar and pestle. Powder quantity equivalent to 50 
mg was taken and dissolved in 100 ml of PH 7.2 phosphate buffer. 
From the above drug solution, 1 ml was withdrawn and diluted with 
9 ml of PH 7.2 phosphate buffer. The solution was then filtered using 
a Whatman filter paper [20]. The absorbance of the filtered drug 
solution was measured by using a UV-VIS spectrophotometer 
(Thermo Spectronic UV-1, USA) at λmax 220 nm and the drug content 
was determined by the following equation- 
 
Swelling study 
Swelling study was performed by placing an accurately weighed 
tablet in a petri dish containing 20 ml of phosphate buffer PH 7.2. 
The tablets were withdrawn at the predetermined time interval and 
the excess amount of fluid was soaked by a tissue paper [30, 31]. 
Then the tablet was weighed and the percentage weight gain was 
calculated by following formula- 
 
Where, Wt = Weight of tablet after time “t” 
Wo
The swelled tablet sample was collected and after drying it was 
coated with metal by using an ion sputtering device. The coated 
sample was then mounted on SEM instrument and the morphology 
of the surface was examined by SEI detector [32]. 
 = Initial weight of the tablet. 
Scanning electron microscopy 
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In vitro drug release studies 
Dissolution of the tablets was carried out on USP type II paddle type 
dissolution apparatus (Veego VDA-6D, Veego Instruments Co-
operation, India). According to I. P. 7.2 phosphate buffer was 
selected as dissolution medium and the volume was maintained 900 
ml. The temperature of the medium was set at 37±0.5 °C. The 
rotational speed of paddle was set at 50 rpm. 10 ml of sample was 
withdrawn at predetermined interval up to 8 h and the same volume 
of fresh dissolution medium was replaced for maintaining sink 
condition. The withdrawn samples were filtered and analyzed by 
UV-VIS spectrophotometer (Thermo Spectronic UV-1, USA) at λmax 
220 nm using PH 7.2 phosphate buffer as a blank and the cumulative 
percentage of drug release was calculated [20]. 
Release Kinetics 
In order to understand the mechanism and kinetics of drug release, 
the result of the in vitro drug release study of formulated tablets 
were fitted with various kinetic equations, such as zero-order 
(percentage release versus time), first-order (log percentage of 
cumulative drug remaining versus time), Higuchi’s model 
(percentage drug release versus square root of time), Korsmeyer-
Peppas model (log cumulative amount versus log time). Correlation 
coefficient (R2) values were calculated for the linear curves obtained 
by regression analysis of the above plots [33-35]. 
Zero-order kinetics 
The zero order rate describes the systems where the drug release 
rate is independent of its concentration. 
A zero order release would be predicted by the following equation,  
 
Where, 
Qt = Amount of drug release dissolved in time ‘t’. 
Qo = Initial amount of drug concentration in solution. 
K0 = Zero order rate constant. 
When the data was plotted as cumulative % drug release Vs time, if 
the plot is linear then data obeys zero order kinetics with slope 
equal to K0. This model represents an ideal release profile in order 
to achieve the prolonged pharmacological action. 
First order kinetics 
The first order describes the release from the system where release 
rate is concentration dependent. 
A first order release would be predicted by the following equation 
 
Where,  
Qt = Amount of drug released in time ‘t’. 
Qo = Initial amount of drug concentration in solution.  
K1t = First order rate constant 
When data were plotted as log cumulative % drug remaining verses 
time yields a straight line indicating that the release follows first order 
kinetics. The constant Kcan be obtained multiplying slope values. 
Higuchi’s model 
Higuchi described the release of drugs from the insoluble matrix as a 
square root of a time-dependent process based on Fickian diffusion. 




K =constant reflecting design variable system 
t = time in hours. 
Korsmeyer-peppas equation 
This model describes drug release from a polymeric system. To find 
out the mechanism of drug release, an initial 60% drug release data 
were fitted in the Korsmeyer-Peppas model. 
To evaluate the mechanism of drug release, it was further plotted in 




Mt/Mα  = fraction of drug released at time t  
t = Release time  
K = Kinetic constant (incorporating structural and geometric 
characteristics of preparation) 
n = Diffusional exponent indicative of the mechanism drug  
This model is used to analyze the release of pharmaceutical 
polymeric dosage forms depending on ‘n’ value when the release 
mechanism is not known or more than one type of release 
phenomenon was involved. n ≤ 0.43 symbolize Fickian release, 
0.43<n<0.85 symbolize non-Fickian release, and n ≥ 0.85 indicates a 
case II transport. 
Hixson-crowell 
The Hixson-Crowell model describes the release from systems 




Qt = remaining amount of drug in the dosage form at time t, 
Q0 = initial amount of the drug in the tablet  
KHC 
RESULTS AND DISCUSSION 
= rate constant for Hixson-Crowell rate equation 
Fourier transform infrared spectroscopy (FT-IR) 
FTIR spectrum of ibuprofen and formulation was shown in Fig.1. 
FTIR spectrum of ibuprofen shows the peak at 2955.47 cm-1 for C-
H stretching of alkane which is observed in the formulation at 
2956.25 cm-1. Peaks for C=O stretching for carboxylic acid shows 
peak at1722.58 cm-1which can be observed in the formulation at 
1718.82 cm-1. C-C stretching in the aromatic ring is observed for 
pure ibuprofen at 1418.10 cm-1which is observed in the 
formulation at 1437.72 cm-1. C-O stretching for carboxylic acid 
shows peak at 1183.03 cm-1which is also present in the 
formulation at 1184.23 cm-1. O-H bending for carboxylic acid is 
observed at 936.73 cm-1 which can be seen in the formulation at 
932.47 cm-1
The saturated solubility of ibuprofen and solid dispersed ibuprofen 
in distilled water was shown in table 3. The result of solubility 
studies indicated that ibuprofen is having low aqueous solubility in 
room temperature. The saturation solubility of ibuprofen was found 
. The characteristic peaks appeared in the FTIR 
spectrum of ibuprofen is observed in the formulation without any 
significant shifting of peaks which indicates the absence of any 
chemical or physical interaction during and after preparation. 
Post-compression parameters 
Post-compression parameters such as tablet thickness, hardness, 
friability, and weight variation tests were carried out for prepared 
ibuprofen solid dispersed tablets and the results were found within 
the specified limits (table 2). 
Saturated solubility 
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to increase in solid dispersed ibuprofen. An increase in the 
concentration of PEG 6000 in the physical mixture of solid dispersed 
ibuprofen increased the saturation solubility of ibuprofen. This 
phenomenon could be due to the enhanced wetting property of 
ibuprofen [36, 37]. 
Drug content 
The average drug content was calculated for each formulation. The 
drug content for prepared solid dispersed formulation was found to 
be within the range of 98.68±0.71% to 99.38±0.46 % (table 2). 
 
 
Fig. 1: FT-IR spectrum of–(A)-pure ibuprofen and (B)-formulation mixture 
 
Table 2: Post-compression parameters of ibuprofen matrix tablets 
Formulation code Thickness* Weight variation test (mm)±SD ** Hardness (%)±SD  * (Kg/cm3 Friability)±SD  * (%)±SD (n=10) 
F1 3.28±0.036 497±1.80 5.75±0.26 0.61±0.07 
F2 3.34±0.073 499±1.63 5.64±0.87 0.52±0.04 
F3 3.24±0.029 498±1.14 5.43±0.49 0.47±0.05 
F4 3.37±0.062 497±1.38 5.48±0.52 0.54±0.03 
F5 3.31±0.058 497±1.72 5.61±0.42 0.51±0.05 
F6 3.26±0.071 499±1.47 5.32±0.28 0.42±0.06 
*n = 10;** n=20; SD-Standard deviation 
 
Table 3: Saturated solubility, percentage drug content and swelling index of prepared ibuprofen solid dispersed matrix tablets 
Formulation code Saturated solubility mg/ml % Drug content mean±SD Swelling index %±SD at SIF pH=7.2 
F1 1.82±0.07 98.27±0.80 90±5.43 
F2 3.27±0.24 97.35±0.46 99±4.28 
F3 3.41±0.18 99.17±0.54 113±8.76 
F4 3.53±0.27 98.93±0.67 118±7.42 
F5 3.59±0.34 97.28±0.52 126±5.87 
F6 3.86±0.39 98.79±0.39  137±6.41 
n = 3; SD-Standard deviation 
 
Swelling study 
The swelling characteristics of solid dispersed matrix tablets of 
ibuprofen were studied in simulated intestinal fluid (P
The surface morphology and porosity for the swelled tablet matrix 
was examined by scanning electron microscope. Fig. 2 displays the 
SEM image of F6 formulation. It is clearly observed from the image 
H 7.2). The 
swelling index for all the formulation was found within the limit of 
90±5.43 to 137±6.41 as given in table 3. From the above data it can 
be predicted that with the increase in the hydrophilic polymer in the 
formulation, the swelling index increased gradually. There was 
gradual disintegration found on the swollen tablet which created 
pores in tablet surface that has facilitated fluid penetration.  
Scanning electron microscope 
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that the tablet surface is rough and porous in nature. The uneven 
swelling was achieved because of the unequal swelling of 
hydrophilic and hydrophobic polymers which created channels 




Fig. 2: SEM image of swollen tablet surface 
In vitro drug release study 
To understand the drug release profile from solid dispersed tablets 
of ibuprofen in vitro release study was performed in phosphate 
buffer at pH 7.2 up to 8 h. Then the cumulative percentage release 
was calculated. The cumulative percentage drug released Vs time 
plot is shown in fig. 3 for all formulations. The cumulative percent 
drug release after 8 h of dissolution was found to be within the range 
of 68.76±3.04 to 95.33±2.34 %. The drug release was gradually 
increased with a higher concentration of carbopol which is a 
hydrophilic polymer. A higher amount of hydrophobic polymer 
tends to decrease the release of the drug. Due to the high viscosity of 
the polymers sustained release of ibuprofen was achieved [38].  
In vitro release kinetics 
The release kinetics of various formulations is described in table 4. The 
average percentage release was fitted into different release models: 
Zero order, First order, Higuchi’s plot, korsmeyer-peppas, and Hixson-
Crowell model. The correlation coefficients for formulations F1, F2, F3, 
F4, F5 and F6 are calculated from respective graphs. Based on the 
correlation values the release mechanism for F1, F2, F5, and F6 were 
found to follow korsmeyer-peppas kinetics for which value was found 
within the range of 0.290-0.33, indicating an anomalous behaviour 
(non-Fickian kinetics corresponding to coupled diffusion/polymer 
relaxation). F3 and F4 followed Hixson-Crowell model. 
 
 
Fig. 3: Comparative C. P. R. of ibuprofen from solid dispersed matrix tablets (number of experiments, n = 3; data given in mean±SD) 
 
Table 4: Result of curve fitting of in vitro release of ibuprofen from solid dispersed matrix tablets 
Formulation 
code 
Zero order R First order R2 Higuchi R2 Korsmeyer-peppas 2 Hixson-crowell 
R
Best fit model 
2 R N 2 
F1 1.50 0.922 0.927 0.935 0.251 0.925 Korsmeyer-Peppas 
F2 0.98 0.975 0.970 0.967 0.290 0.965 Korsmeyer-Peppas 
F3 0.80 0.960 0.921 0.965 0.313 0.004 Hixson-Crowell 
F4 0.16 0.978 0.990 0.986 0.336 0.002 Hixson-Crowell 
F5 0.20 0.918 0.978 0.965 0.308 0.961 Korsmeyer-Peppas 
F6 0.11 0.857 0.968 0.959 0.311 0.729 Korsmeyer-Peppas 
 
CONCLUSION 
The objective of the present research was to formulate solid 
dispersed tablets of ibuprofen to improve the dissolution rate and to 
investigate the effect of the combination of hydrophilic and 
hydrophobic polymers on drug release. The drug and excipient 
compatibility was checked by FT-IR. Solid dispersed tablets of 
ibuprofen were prepared by direct compression method with solid 
dispersed ibuprofen. Saturated solubility was examined in distilled 
water and it was found to increase for solid dispersed ibuprofen. The 
swelling study was also performed for all the formulation and 
swelling index was found satisfactory. After swelling, SEM image of 
the tablet surface confirmed the presence of numerous pores and 
swelled tablet surface. Then tablets were evaluated for in vitro drug 
release study which was carried out in phosphate buffer P
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